pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Here's how many clinicians are using AI to answer their medical questions

New research illustrates the rapid rise of clinicians’ use of AI to answer medical questions despite little evidence of how it affects decision-making or patient outcomes. Researchers studied usage data from OpenEvidence, an AI search ...

Oct 16, 2026·read at Endpoints ↗

October 16, 2026 09:00 AM EDT Health Tech Here's how many clin­i­cians are us­ing AI to an­swer their med­ical ques­tions Shelby Livingston Health tech correspondent New re­search il­lus­trates the rapid rise of clin­i­cians’ use of AI to an­swer med­ical ques­tions de­spite lit­tle ev­i­dence of how it af­fects de­ci­sion-mak­ing or pa­tient … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
85 words · retrieved 14m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoEx-Genentech scientist joins Ira Mellman at Medici; Intellia poaches CMO from Scholar RockEndpoints
  • 3h agoEstuary debuts with $103M to develop kidney disease gene therapiesEndpoints
  • 3h agoCity Therapeutics lands $200M IPO as it builds an Alnylam 2.0 in RNAi fieldEndpoints
  • 19h agoCDC page supporting Covid vaccines for pregnancy went darkEndpoints
  • 20h agoVirginia leads in winning investments as drugmakers onshore to the USEndpoints